Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minodronic acid tablets in postmenopausal osteoporosis
CTR20150542Phase 3Active
- Sponsor
- Shandong Innovative Pharmaceutical Research and Development
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minodronic acid in postmenopausal osteoporosis, sponsored by Shandong Innovative Pharmaceutical Research and Development. Started Aug 2015; status: active.
02
Drugs
minodronic acid
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on CTR20150542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150542.